State Street’s Gilead Sciences GILD Stock Holding History

State Street’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.34B	Sell	59,858,585 -381,933	-0.6%	-$53.5M	0.29%	62
2025 Q4	$7.39B	Buy	60,240,518 +1,151,213	+2%	+$140M	0.25%	76
2025 Q3	$6.56B	Sell	59,089,305 -98,855	-0.2%	-$11.2M	0.23%	82
2025 Q2	$6.56B	Sell	59,188,160 -335,515	-0.6%	-$35.7M	0.25%	74
2025 Q1	$6.67B	Sell	59,523,675 -858,080	-1%	-$88.5M	0.27%	65
2024 Q4	$5.58B	Buy	60,381,755 +210,064	+0.3%	+$18.9M	0.22%	81
2024 Q3	$5.04B	Buy	60,171,691 +841,776	+1%	+$64.2M	0.21%	89
2024 Q2	$4.07B	Buy	59,329,915 +1,624,987	+3%	+$108M	0.18%	104
2024 Q1	$4.23B	Sell	57,704,928 -1,831,497	-3%	-$141M	0.19%	104
2023 Q4	$4.82B	Buy	59,536,425 +651,378	+1%	+$50.7M	0.23%	79
2023 Q3	$4.41B	Sell	58,885,047 -432,115	-0.7%	-$33.2M	0.24%	75
2023 Q2	$4.57B	Buy	59,317,162 +1,514,894	+3%	+$121M	0.24%	78
2023 Q1	$4.8B	Sell	57,802,268 -1,139,105	-2%	-$94.3M	0.27%	74
2022 Q4	$5.06B	Sell	58,941,373 -298,977	-0.5%	-$23.7M	0.3%	65
2022 Q3	$3.65B	Buy	59,240,350 +1,293,414	+2%	+$81.6M	0.23%	83
2022 Q2	$3.58B	Sell	57,946,936 -24,023	-0%	-$1.49M	0.21%	90
2022 Q1	$3.45B	Buy	57,970,959 +601,690	+1%	+$38.5M	0.17%	114
2021 Q4	$4.17B	Buy	57,369,269 +2,187,144	+4%	+$151M	0.2%	94
2021 Q3	$3.85B	Buy	55,182,125 +882,466	+2%	+$62M	0.2%	89
2021 Q2	$3.74B	Buy	54,299,659 +829,887	+2%	+$55.4M	0.2%	93
2021 Q1	$3.46B	Sell	53,469,772 -1,736,787	-3%	-$112M	0.2%	99
2020 Q4	$3.22B	Sell	55,206,559 -1,786,770	-3%	-$108M	0.2%	101
2020 Q3	$3.6B	Sell	56,993,329 -1,033,383	-2%	-$71.7M	0.25%	82
2020 Q2	$4.46B	Buy	58,026,712 +1,221,502	+2%	+$93.6M	0.32%	65
2020 Q1	$4.25B	Sell	56,805,210 -1,263,553	-2%	-$87.3M	0.37%	58
2019 Q4	$3.77B	Buy	58,068,763 +686,663	+1%	+$44.7M	0.26%	78
2019 Q3	$3.64B	Sell	57,382,100 -102,073	-0.2%	-$6.67M	0.27%	76
2019 Q2	$3.88B	Sell	57,484,173 -1,165,470	-2%	-$76.7M	0.29%	68
2019 Q1	$3.81B	Buy	58,649,643 +2,534,199	+5%	+$168M	0.3%	70
2018 Q4	$3.51B	Buy	56,115,444 +100,137	+0.2%	+$7M	0.32%	63
2018 Q3	$4.32B	Buy	56,015,307 +1,577,990	+3%	+$119M	0.33%	57
2018 Q2	$3.86B	Buy	54,437,317 +523,975	+1%	+$37M	0.32%	59
2018 Q1	$4.06B	Sell	53,913,342 -2,561,897	-5%	-$204M	0.35%	56
2017 Q4	$4.05B	Buy	56,475,239 +1,062,022	+2%	+$80.7M	0.33%	59
2017 Q3	$4.49B	Sell	55,413,217 -2,706,594	-5%	-$207M	0.39%	52
2017 Q2	$4.11B	Sell	58,119,811 -1,886,389	-3%	-$126M	0.36%	51
2017 Q1	$4.08B	Sell	60,006,200 -442,631	-0.7%	-$31.1M	0.36%	50
2016 Q4	$4.33B	Buy	60,448,831 +2,587,072	+4%	+$192M	0.41%	49
2016 Q3	$4.58B	Buy	57,861,759 +4,721,277	+9%	+$384M	0.46%	44
2016 Q2	$4.43B	Sell	53,140,482 -1,592,766	-3%	-$141M	0.48%	44
2016 Q1	$5.03B	Sell	54,733,248 -3,186,946	-6%	-$287M	0.54%	36
2015 Q4	$5.86B	Sell	57,920,194 -451,805	-0.8%	-$47M	0.64%	30
2015 Q3	$5.73B	Sell	58,371,999 -665,580	-1%	-$73.9M	0.67%	27
2015 Q2	$6.91B	Sell	59,037,579 -3,157,904	-5%	-$345M	0.74%	22
2015 Q1	$6.1B	Sell	62,195,483 -2,457,818	-4%	-$250M	0.63%	28
2014 Q4	$6.09B	Buy	64,653,301 +2,477,098	+4%	+$256M	0.61%	33
2014 Q3	$6.62B	Buy	62,176,203 +649,609	+1%	+$63.6M	0.71%	24
2014 Q2	$5.1B	Buy	61,526,594 +416,554	+0.7%	+$32.4M	0.55%	34
2014 Q1	$4.33B	Sell	61,110,040 -1,758,548	-3%	-$138M	0.49%	40
2013 Q4	$4.72B	Sell	62,868,588 -40,815	-0.1%	-$2.84M	0.53%	39
2013 Q3	$3.95B	Buy	62,909,403 +533,169	+0.9%	+$31.9M	0.49%	40
2013 Q2	$3.19B	Buy	+62,376,234	New	+$3.25B	0.42%	45

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street's GILD Position: Q1 2026 in Review

State Street reduced its Gilead Sciences (GILD) stake by 0.63% in Q1 2026, selling an estimated $53.5M and leaving 59,858,585 shares worth $8.34B. The position accounts for 0.29% of the portfolio, ranked #62.

State Street first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

State Street held 59,858,585 shares of Gilead Sciences worth $8.34B as of Q1 2026.
State Street sold 381,933 Gilead Sciences shares in Q1 2026, an estimated $53.5M.
Gilead Sciences made up 0.29% of State Street's portfolio in Q1 2026, its #62 holding.
State Street first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.